According to recent research at the Stony Brook University Cancer Center, Avastin, the cancer drug, increases the risk of blood clot in the veins by about 33% when taken together with chemotherapy.
For the study, which was published in The Journal of the American Medical Association, 15 previous clinical trials involving a total of nearly 8,000 persons found that Avastin, which is marketed by Roche and Genentech, increased the risk of blood clots from about 10% to about 13%.
According to Dr Shenhong Wu, leader of the study, this is “a significant increased risk with Avastin for patients while they are taking chemotherapy”.
Related posts:
- Questions About Chemotherapy and Cancer Drugs Often, we are told of the safety and effectiveness of...
- Exposure to Chemicals Benzene, Xylene and Toluene Increases Cancer Risk According to recent research in Italy, being exposed to benzene,...
- Choosing Alternative Cancer Treatment, and Knowing the Failings of Chemotherapy Many people turn to natural and herbal remedies for many...
- If Oncologists Won’t Use Chemotherapy, Why Should Anyone? Would you allow a car mechanic who does not know...
- Study Finds High Blood Insulin Levels Raise Breast Cancer Risk A study conducted by researchers from the Albert Einstein College...